Patent · US Active

Method of treating retinopathy with an anti-LRP5 antibody

US10035854B2 · kind B2 · utility

0Cited by
0References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 11, 2016
Grant dateJul 31, 2018
Priority date—
Expiry dateNov 11, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-LRP5 antibodies and methods of making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.